Novo files N8-GP in the US and EU

28th February 2018 Uncategorised 0

Novo Nordisk has filed regulatory applications in the US and European Union seeking approval to market N8-GP for the treatment of haemophilia

More: Novo files N8-GP in the US and EU
Source: News